Emrelis 00074-1044
Generic: Telisotuzumab Vedotin
Product NDC
00074-1044- Manufacturer
- Abbvie Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 14, 2025
- Listing Expires
- December 31, 2026
- Application
- BLA761384
Need to source Emrelis? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Telisotuzumab Vedotin | 20 mg/mL |
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1044-01) / 1 mL in 1 VIAL, SINGLE-DOSE